Polyurethane-Derived Microplastics and Nanoplastics: Sources, Human Exposure, and Toxicological and Health Effects
- 1Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, 51-616 Wroclaw, Poland
Abstract
Polyurethane (PU) is one of the most widely used synthetic polymers, yet polyurethane-derived microplastics and nanoplastics (MNPs) have received less attention than particles derived from polyethylene, polypropylene, or polystyrene. This narrative review summarizes current evidence on the sources, environmental release, aging, human exposure pathways, biomonitoring findings, biological effects, and research gaps associated with PU-derived MNPs. The review synthesized 200 sources from database searches without publication-date restrictions and supplementary contextual literature, integrating environmental, experimental, biomonitoring, and clinical evidence, considering methodological limitations and publication status. PU-derived MNPs originate from diverse consumer, industrial, textile, medical, and agricultural products and undergo physicochemical transformations during environmental aging that may alter particle behavior and chemical release. Human exposure may occur through inhalation, ingestion, dermal contact, and medical procedures, while PU-containing particles have been detected in biological matrices, including respiratory samples, placenta, blood, reproductive tissues, and urine. Experimental evidence suggests that PU-derived particles and their associated leachates may induce oxidative stress, inflammation, barrier dysfunction, cytotoxicity, and immune responses, although direct evidence linking PU exposure to human disease remains limited. Integrating environmental monitoring, human biomonitoring, toxicology, and One Health approaches can improve exposure assessment, harmonize analytical methods, and clarify the ecological and clinical relevance of PU-derived MNPs.
Related
- Microplastics and nanoplastics from food packages: linking contamination and exposure to potential health impacts and mitigation strategies
- Persistent influx of atmospheric microplastics and nanoplastics to Mount Everest driven by large scale circulation
- Shape-dependent polyurethane microplastics reprogram root architecture and detoxification modules to suppress cadmium uptake in a hyperaccumulator
- A perspective on the potential impact of microplastics and nanoplastics on the human central nervous system
- Effects of Polymer Morphology on Humic Acid Adsorption onto Model Microplastics and Nanoplastics
BibTeX
@article{pietrzak2026polyurethanederived,
title = {{Polyurethane-Derived Microplastics and Nanoplastics: Sources, Human Exposure, and Toxicological and Health Effects}},
author = {Magdalena Pietrzak and Adrian Kawecki and Magdalena Zemelka-Wiacek},
journal = {Molecules},
year = {2026},
month = oct,
doi = {10.3390/molecules31193517},
url = {https://www.mdpi.com/1420-3049/31/19/3517},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Polyurethane-Derived Microplastics and Nanoplastics: Sources, Human Exposure, and Toxicological and Health Effects
AU - Magdalena Pietrzak
AU - Adrian Kawecki
AU - Magdalena Zemelka-Wiacek
PY - 2026
DA - 2026/10/02
JO - Molecules
DO - 10.3390/molecules31193517
UR - https://www.mdpi.com/1420-3049/31/19/3517
AB - Polyurethane (PU) is one of the most widely used synthetic polymers, yet polyurethane-derived microplastics and nanoplastics (MNPs) have received less attention than particles derived from polyethylene, polypropylene, or polystyrene. This narrative review summarizes current evidence on the sources, environmental release, aging, human exposure pathways, biomonitoring findings, biological effects, and research gaps associated with PU-derived MNPs. The review synthesized 200 sources from database searches without publication-date restrictions and supplementary contextual literature, integrating environmental, experimental, biomonitoring, and clinical evidence, considering methodological limitations and publication status. PU-derived MNPs originate from diverse consumer, industrial, textile, medical, and agricultural products and undergo physicochemical transformations during environmental aging that may alter particle behavior and chemical release. Human exposure may occur through inhalation, ingestion, dermal contact, and medical procedures, while PU-containing particles have been detected in biological matrices, including respiratory samples, placenta, blood, reproductive tissues, and urine. Experimental evidence suggests that PU-derived particles and their associated leachates may induce oxidative stress, inflammation, barrier dysfunction, cytotoxicity, and immune responses, although direct evidence linking PU exposure to human disease remains limited. Integrating environmental monitoring, human biomonitoring, toxicology, and One Health approaches can improve exposure assessment, harmonize analytical methods, and clarify the ecological and clinical relevance of PU-derived MNPs.
SN - 1420-3049
ER -